前列环素在风湿疾病的应用分析.pptVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
还能显著减轻风湿性疾病患者疼痛。与对照组相比,两组具有显著性差异 RESULTS: There?was a trend towards fewer digital ulcerations in the BPS group than the placebo group (48.1 vs 58.8%, delta = 10.7%, p = 0.325), and median survival without recurrence of digital ulceration was longer in the BPS group (log-rank test, p = 0.233). Overall well being improved significantly more in the BPS group (p = 0.047), and von Willebrand factor decreased significantly more in the BPS group (p = 0.0001). The trend towards fewer digital ulcerations was more markedly in favor of BPS in the distal SSc group (delta for digital ulceration = 20.9%, p = 0.248) with a later onset (log-rank test, p = 0.057). Fewer patients were hospitalized in the BPS than the placebo group (4.0 vs 17.4%, p = 0.18). Side effects were mild. * Giant capillaries 是一个病理指标, 当出现时代表疾病的早期,特别是风湿疾病。凯那显著减少患者giant capillary数量。 * 血管性假性血友病因子(vWF),内皮功能损害的重要标志物之一 血中Von-Willebrand因子(血管性假性血友病因子,VwF)水平增高,说明硬皮病血管炎患者的内皮细胞被激活。VwF因子有活化血小板和促进血小板粘附的作用,促发血管内凝血,还能使成纤维细胞趋化和分裂的作用,使成纤维细胞分泌大量胶原,导致内膜纤维化。由损伤的血管壁向外渗透时,可导致外膜和血管周围组织纤维化。 而凯那能显著降低血管假性血友病因子减轻血管内皮损害。 * 有一个125例雷诺现象患者入选的试验,该试验把患者分为了贝前组和安慰剂组,来观察贝前的治疗效果。 研究的是雷诺现象的发生频率、严重程度,总体致残率等 J Rheumatol. 1996 Nov;23(11):1917-20. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynauds phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes. Vayssairat M. Author information H?pital Tenon, Paris, France. Abstract OBJECTIVE: To compare the efficacy and tolerance of beraprost sodium, an oral prostanoid prostaglandin I2 analog, with a placebo in patients with primary Raynauds phenomenon (RP). METHODS: 125 patients with disabling primary RP participated in a multicenter, randomized, double blind trial in 2 parallel groups, lasting 8 weeks, and conducted during the winter months only; a meteorological survey was also conducted for each patient. Main outcome measures were frequency and severity of attacks of RP, overall disabil

文档评论(0)

baobei + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档